Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Vita Life Sciences Limited ( (AU:VLS) ) is now available.
Vita Life Sciences Limited has cancelled 102,152 fully paid ordinary shares on 5 March 2026 following completion of an on-market buy-back. The reduction in issued capital may slightly enhance value per remaining share and signals ongoing capital management activity to the market and existing shareholders.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an Australia-listed company on the ASX under the code VLS. It operates in the life sciences and healthcare sector, although this filing does not specify its particular product lines, services, or geographic market focus.
Average Trading Volume: 14,886
Technical Sentiment Signal: Buy
Current Market Cap: A$142M
Learn more about VLS stock on TipRanks’ Stock Analysis page.